Results 201 to 210 of about 60,513 (321)

Fibrocytes in primary myelofibrosis

open access: yesOncotarget, 2021
Kazuya Shimoda   +2 more
openaire   +2 more sources

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

open access: yesNew England Journal of Medicine, 2012
C. Harrison   +13 more
semanticscholar   +1 more source

Immune thrombocytopenia in postpolythemic myelofibrosis [PDF]

open access: bronze, 1997
Zwi A. Schreiber
openalex   +1 more source

Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?

open access: yesBlood Cancer Journal
Giovanni Barosi   +7 more
doaj   +1 more source

A rare case of extramedullary hematopoiesis: when the pericardium produces blood cells. [PDF]

open access: yesEgypt Heart J
Hayar SE   +9 more
europepmc   +1 more source

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial

open access: yesJAMA Oncology, 2018
J. Mascarenhas   +18 more
semanticscholar   +1 more source

Autoimmune Myelofibrosis

open access: bronze, 1994
Ronald Paquette   +2 more
openalex   +1 more source

Hypercalcemia and adrenal insufficiency in a patient with myelofibrosis [PDF]

open access: bronze, 2000
Mark Hertzberg, Mark Wong
openalex   +1 more source

Long‐term survival of infants with idiopathic myelofibrosis [PDF]

open access: bronze, 2000
Rachel A. Altura   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy